With the development of nanotechnology, nanoparticles (NPs) have shown broad prospects
as drug delivery vehicles. However, they exhibit certain limitations, including low …

The diagnosis and treatment of solid tumors have undergone significant advancements
marked by a trend toward increased specificity and integration of imaging and therapeutic …

Cancer nanomedicine has emerged as a promising approach to overcome the limitations of
conventional cancer therapies, offering enhanced efficacy and safety in cancer …

The biomedical applications of magnetic nanoparticles (MNPs) have gained increasing
attention due to their unique biological, chemical, and magnetic properties such as …

Because therapeutic cancer vaccines can, in theory, eliminate tumor cells specifically with
relatively low toxicity, they have long been considered for application in repressing cancer …

Inspired by the concept of “natural camouflage,” biomimetic drug delivery systems have
emerged to address the limitations of traditional synthetic nanocarriers, such as poor …

Globally, cancer is one of the deadliest diseases, needing a meticulous diagnosis and
targeted treatment plan to achieve an initial prognosis, followed by precision and …

Although chemotherapy with magnetic nanocarriers has witnessed significant advancement
in the field of cancer treatment, multimodal diagnosis and combinatorial therapy using a …

An efficient strategy for passive delivery of doxorubicin (DOX) to the breast (MDA-MB-231)
and lung (A-549) cancer cells is presented and compared with MCF-10A normal breast …

Cell penetrating peptides (CPPs) are usually positive charged peptides and have good cell
membrane permeability. Meanwhile, CPPs are facile to synthesize, and can be …